Peptides ArchiveAll Peptide Resources in One Archive
Research Use OnlyScientific, regulatory and product-reference information only. No medical advice or human-use recommendation.Compliance Hub

Peptide Reference Desk

Tirzepatide analysis: what the fatty-acid side chain changes in LC-MS and impurity control

Tirzepatide is a lipidated, multi-receptor peptide whose conjugated structure requires more than an intact-mass match and generic HPLC purity result.

Tirzepatide archive searchResearch Use OnlyGLP-1 Peptides

The side chain is part of the active structure

Tirzepatide is a 39-residue peptide with noncanonical residues and a C20 fatty diacid attached through a linker. That lipidated side chain contributes to albumin binding and prolonged exposure. An analysis that confirms only the peptide backbone is incomplete.

Orthogonal identity is essential

Intact LC-HRMS can support overall mass, but isomeric sequence errors, attachment-site mistakes and closely related conjugates may survive an intact-mass screen. Peptide mapping, diagnostic fragments and comparison with a qualified reference material strengthen assignment.

Quality questionAnalytical response
Correct backbone?Sequence-resolving peptide map or MS/MS
Correct conjugation?Attachment-site and linker confirmation
Related substances?Stability-indicating LC with impurity resolution
Net peptide content?Validated assay corrected for water/counterion as applicable
Aggregation?Appropriate orthogonal size or particle methods

Sample handling can create the impurity

Lipidated peptides can show adsorption, solubility and carryover problems. Diluent, vial surface, needle wash, temperature and hold time should be qualified. A disappearing main peak may reflect poor recovery rather than chemical degradation; a late carryover peak may contaminate the next injection.

Why a vendor chromatogram is not enough

A chromatogram without method, wavelength, integration rules, system suitability and sample basis cannot establish identity or content. “Greater than 99%” should be treated as one result within a larger release package, not a complete quality conclusion.

Verify with primary records

Use the primary paper, current regulator label or lot-linked analytical file for the claim it supports. A search result is a route to evidence, not the evidence itself.

Research-use reference only. No dosing, administration, compounding or human-use guidance is provided.